Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serlopitant for Refractory Chronic Cough
NCT03282591Phase 2Completed
- Sponsor
- Vyne Therapeutics
- Start
- Oct 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of serlopitant in refractory chronic cough (RCC), sponsored by Vyne Therapeutics. Started Oct 2017; status: completed.
02
Drugs
serlopitant
03
Conditions
refractory chronic cough (RCC)
Beyond the preview
Go deeper on NCT03282591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03282591.